Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;
2023-SR-508
Unknown small_molecule active
Quick answer
Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration; for Acute Myeloid Leukemia is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Acute Myeloid Leukemia
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active